Traditionally, influenza vaccine seed viruses have been made by classical reassortment by choosing a virus isolate which closely matches circulating strains, and introducing its surface glycoprotein gene segments (HA and NA) into the genetic background of the laboratory-adapted and high-yielding “PR8” virus, A/Puerto Rico/8/34 (H1N1). Here, XK is linked to influenza.